Odyssey Therapeutics, Inc.
Ticker: 1882782
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY25 | Q1 FY25 |
|---|---|---|
| INCOME | ||
| Revenue | 0.96-50.0% | 1.92 |
| Total Income | 0.96-50.0% | 1.92 |
| EXPENSES | ||
| Expenditure | 42.88+4.4% | 41.08 |
| Tax | 0.03-78.6% | 0.14 |
| PROFIT | ||
| PBT | -41.21-7.6% | -38.30 |
| Net Profit | -41.24-7.3% | -38.44 |
| KEY METRICS | ||
| OPM % | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% |
| EPS | -29.54+25.0% | -39.37 |
Corporate Events
No corporate events found.